XBiotech Inc.
XBIT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $81 | $91 | $99 | $120 |
| - Cash | $147 | $153 | $156 | $173 |
| + Debt | $0 | $0 | $0 | $10 |
| Enterprise Value | -$66 | -$62 | -$57 | -$42 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$1 | -$10 | -$10 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$2 | -$11 | -$11 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.2 | -0.058 | -0.36 | -0.34 |
| % Growth | -247.2% | 84% | -5.9% | – |
| Operating Cash Flow | -$4 | -$6 | -$7 | -$7 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$6 | -$7 | -$7 |